Trial
NCT03447730
Safety, Tolerability and Pharmacodynamics of SYNB1020
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Synlogic
Collaborators
—
Condition
Cirrhosis
Intervention
SYNB1020
Why stopped
Interim futility analyses identified a lack of SYNB1020 efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-13